Related Experiment Video

Updated: Mar 27, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era

T Kobayashi¹, J Kuroda¹, I Yokota²

¹Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Blood Cancer Journal

|January 16, 2016

Abstract

No abstract available in PubMed .

More Related Videos

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Complex molecular genetic abnormalities involving three or more genetic mutations are important prognostic factors for acute myeloid leukemia.

Leukemia·2015

The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias.

Cell death and differentiation·2008

Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia.

Cell death and differentiation·2007

Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells.

Molecular and cellular biology·2001

Membrane associated antitumor effects of crocine-, ginsenoside- and cannabinoid derivates.

Anticancer research·2000

Identification of Cannabis pollens using an allergic patient's immunoglobulin E and purification and characterization of allergens in Cannabis pollens.

Forensic science international·1999

See all related articles